Neuroblastoma: When differentiation goes awry

M Zeineldin, AG Patel, MA Dyer - Neuron, 2022 - cell.com
Neuroblastoma is a leading cause of cancer-related death in children. Accumulated data
suggest that differentiation arrest of the neural-crest-derived sympathoadrenal lineage …

Organoids: The current status and biomedical applications

S Yang, H Hu, H Kung, R Zou, Y Dai, Y Hu… - MedComm, 2023 - Wiley Online Library
Organoids are three‐dimensional (3D) miniaturized versions of organs or tissues that are
derived from cells with stem potential and can self‐organize and differentiate into 3D cell …

Advanced 3D imaging and organoid bioprinting for biomedical research and therapeutic applications

S Maharjan, C Ma, B Singh, H Kang, G Orive… - Advanced Drug Delivery …, 2024 - Elsevier
Organoid cultures offer a valuable platform for studying organ-level biology, allowing for a
closer mimicry of human physiology compared to traditional two-dimensional cell culture …

Toward the next generation of vascularized human neural organoids

M Li, L Gao, L Zhao, T Zou, H Xu - Medicinal research reviews, 2023 - Wiley Online Library
Thanks to progress in the development of three‐dimensional (3D) culture technologies,
human central nervous system (CNS) development and diseases have been gradually …

[HTML][HTML] Next generation organoid engineering to replace animals in cancer drug testing

S Hockney, J Parker, JE Turner, X Todd… - Biochemical …, 2023 - Elsevier
Cancer therapies have several clinical challenges associated with them, namely treatment
toxicity, treatment resistance and relapse. Due to factors ranging from patient profiles to the …

Organoids: development and applications in disease models, drug discovery, precision medicine, and regenerative medicine

Q Yao, S Cheng, Q Pan, J Yu, G Cao, L Li, H Cao - MedComm, 2024 - Wiley Online Library
Organoids are miniature, highly accurate representations of organs that capture the structure
and unique functions of specific organs. Although the field of organoids has experienced …

Retinal organoids in disease modeling and drug discovery: Opportunities and challenges

K Chakrabarty, D Nayak, J Debnath, D Das… - Survey of …, 2024 - Elsevier
Diseases leading to retinal cell loss can cause severe visual impairment and blindness. The
lack of effective therapies to address retinal cell loss and the absence of intrinsic …

Retinal organoids from human-induced pluripotent stem cells: From studying retinal dystrophies to early diagnosis of Alzheimer's and Parkinson's disease

MI Móvio, TH de Lima-Vasconcellos… - Seminars in Cell & …, 2023 - Elsevier
Human-induced pluripotent stem cells (hiPSCs) have provided new methods to study
neurodegenerative diseases. In addition to their wide application in neuronal disorders …

[HTML][HTML] Retinoblastoma: A review of the molecular basis of tumor development and its clinical correlation in sha** future targeted treatment strategies

S Rathore, A Verma, R Ratna, N Marwa… - Indian Journal of …, 2023 - journals.lww.com
Retinoblastoma is a retinal cancer that affects children and is the most prevalent intraocular
tumor worldwide. Despite tremendous breakthroughs in our understanding of the …

Second hit impels oncogenesis of retinoblastoma in patient-induced pluripotent stem cell-derived retinal organoids: direct evidence for Knudson's theory

YP Li, YT Wang, W Wang, X Zhang, RJ Shen… - PNAS …, 2022 - academic.oup.com
Retinoblastoma (Rb) is a type of malignant tumor due to abnormal retinogenesis with
biallelic mutations of the RB1 gene. Its pathogenesis has been proposed as a “two-mutation …